Argus Partners Acted for Zeno Health in raising $25 million
The capital would be utilized to enhance its technological infrastructure
Argus Partners has advised Zeno Health, a health-tech startup and omnichannel pharmacy platform for generic and branded medicines, on raising $25 million in its Series C funding round.
The funding was led by South Korean private equity investor STIC Investments, with participation from existing investor Lightbox Ventures.
Zeno Health aims to utilize the capital to expand its footprint and enhance technological infrastructure. It will also empower the company to make quality healthcare affordable to all and serve at least one crore consumers every month.
Commenting on the development, Siddharth Gadia, the Co-Founder and CEO at Zeno Health remarked, “We are thrilled to welcome STIC as a key partner in our journey. Their investment, coupled with the continued commitment from Lightbox, signifies a resounding endorsement of our mission to make quality healthcare affordable to all. The company remains steadfast in its mission to reach and serve one crore consumers monthly, aspiring to reduce their healthcare expenditure by 50 percent.”
While sharing his views on the funding round, Derrick (Kihyun) Yun, the managing director of STIC stated, “Zeno Health has demonstrated a remarkable commitment in reshaping the healthcare landscape in India. Its vision aligns with our values, and we look forward to contributing to its journey towards making quality healthcare accessible across India.”
The Argus Team partners advising on the matter were Abhinav Bhalaik and Neha Madan. They were supported by associates Rohan Aneja, Abhishek Tripathy and Tanya Nair.